Efficacy of transdermal scopolamine for sialorrhea in patients with amyotrophic lateral sclerosis

References

• Andersen, P. M., Abrahams, S., Borasio, G. D., Carvalho, M. D., Chio, A., Damme, P. V., … Pradat, P. F. (2011). EFNS guidelines on the clinical management of amyotrophic lateral sclerosis(MALS)—Revised report of an EFNS task force. European Journal of Neurology, 19, 360–375.
   PubMed Web of Science ®Google Scholar
• Andersen, P. M., Grönberg, H., Franzen, L., & Funegård, U. (2001). External radiation of the parotid glands significantly reduces drooling in patients with motor neuron disease with bulbar paresis. Journal of the Neurological Sciences, 191, 111–114.10.1016/S0022-510X(01)00631-1
   PubMed Web of Science ®Google Scholar
• Atsuta, N., Watanabe, H., Ito, M., Tanaka, F., Tamakoshi, A., Nakano, I., … Hayashi, I. (2009). Reserch committee on the neurodegenerative diseases of Japan. Age at onset influence on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 276, 163–169.10.1016/j.jns.2008.09.024
   PubMed Web of Science ®Google Scholar
• Bradley, W. G., Anderson, F., Bromberg, M., Gutmann, L., Harati, Y., Ross, M., … ALS CARE study group. (2001). Current management of ALS: Comparison of the ALS CARE database and the AAN practice parameter. Neurology, 57, 500–504.10.1212/WNL.57.3.500
   PubMed Web of Science ®Google Scholar
• Brand, J. J., & Perry, W. L. M. (1966). Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods. Pharmacological Reviews, 18, 895–924.
   PubMed Web of Science ®Google Scholar
• Brodtkorb, E., Wyzocka-Bakowska, M. M., Lillevold, P. E., Sandvik, L., Saunte, C., & Hestnes, A. (1988). Transdermal scopolamine in drooling. Journal of Intellectual Disability Research, 32, 233–237.
   Google Scholar
• Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000). E1 Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1, 293–299.10.1080/146608200300079536
   PubMed Web of Science ®Google Scholar
• Clissold, S. P., & Heel, R. C. (1985). Transdermal hyoscine (scopolamine). Drugs, 29, 189–207.10.2165/00003495-198529030-00001
   PubMed Web of Science ®Google Scholar
• Costa, J., Rocha, M. L., Ferreira, J., Evangelista, T., Coelho, M., & de Carvalho, M. D. (2008). Botulinum toxin type-B improves sialorrhea and quality of life un bulbar-onset amyotrophic lateral sclerosis. Journal of Neurology, 255, 545–550.10.1007/s00415-008-0738-5
   PubMed Web of Science ®Google Scholar
• Gordon, C., Ben-Aryeh, H., Attias, J., Szargel, R., & Gutman, D. (1985). Effect of transdermal scopolamine on salivation. The Journal of Clinical Pharmacology, 25, 407–412.10.1002/jcph.1985.25.issue-6
   PubMed Web of Science ®Google Scholar
• Guy, N., Bourry, N., Dallel, R., Dualé, C., Verrelle, P., Lapeyre, M., & Clavelou, P. (2011). Comparison of radiotherapy types in the treatment of sialorrhea in amyotrophic lateral sclerosis. Journal of Palliative Medicine, 14, 391–395.10.1089/jpm.2010.0308
   PubMed Web of Science ®Google Scholar
• Jackson, C. E., Gronseth, G., Rosenfeld, J., Barohn, R. J., Dubinsky, R., Simpson, C. B., … Herbelin, L. (2009). Randomized double-blind study of botulinum toxin type B for sialorrhea in als patients. Muscle and Nerve, 39, 137–143.10.1002/mus.v39:2
   PubMed Web of Science ®Google Scholar
• Mato, A., Limeres, J., Tomás, I., Muñoz, M., Abuín, C., Feijoo, J. F., & Diz, P. (2010). Management of drooling in disabled patients with scopolamine patches. British Journal of Clinical Pharmacology, 69, 684–688.10.1111/bcp.2010.69.issue-6
   PubMed Web of Science ®Google Scholar
• Shimoda, K., Hoshino, T., Sugiyama, R., Morisaki, T., & Shiotsu, K. (2011). The effect of 5% scopolamine ointment to suppress salivation in patients with neurodegenerative diseases and adverse effects associated with the treatment. Japanese Journal of Hospital Pharmacy, 47, 1157–1160.
   Google Scholar
• Talmi, Y. P., Zohar, Y., Finkelstein, Y., & Laurian, N. (1988). Reduction of salivary flow with scopoderm TTS. Annals of Otology, Rhinology & Laryngology, 97, 128–130.10.1177/000348948809700206
   PubMed Web of Science ®Google Scholar
• Talmi, Y. P., Finkelstein, Y., & Zohar, Y. (1989). Reduction of salivary flow in amyotrophic lateral sclerosis with scopoderm TTS. Head and Neck, 12, 565.10.1002/(ISSN)1097-0347
   Google Scholar
• Talmi, Y. P., Finkelstein, Y., & Zohar, Y. (1990). Reduction of salivary flow with transdermal scopolamine: A four-year experience. Otolaryngology-Head and Neck Surgery, 103, 615–618.10.1177/019459989010300415
   PubMed Web of Science ®Google Scholar
• Tan, E. K., Lo, Y. L., Seah, A., & Auchus, A. P. (2001). Recurrent jaw dislocation after botulinum treatment for sialorrhea in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 190, 95–97.10.1016/S0022-510X(01)00565-2
   PubMed Web of Science ®Google Scholar
• Tassinari, D., Poggi, B., Fantini, M., Tamburini, E., & Sartori, S. (2005). Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients. Supportive Care in Cancer, 13, 559–561.10.1007/s00520-005-0826-3
   PubMed Web of Science ®Google Scholar
• Tysnes, O. B. (2008). Treatment of sialorrhea in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica, 117, 77–81.10.1111/j.1600-0404.2008.01037.x
   Web of Science ®Google Scholar